> Canada and Switzerland have lifted their bans on Novartis ($NVS) flu vaccines saying they are satisifed with information they have received from the company. Story
> Sweden-based Pharmalink has signed a manufacturing contract with Patheon for Nefecon that is in development to address the pathology of IgA nephropathy. Story
> Officials in Tanzania have accused a manufacturer there of having produced counterfeit HIV medication. Story
> Discovery Park, the site of a former Pfizer ($PFE) plant in the U.K., has been given Enterprise Zone status so it can provide cost incentives to help it attract the life science clients it is seeking. Story
> Rite Aid ($RAD) reported a 1.1% drop in same-store sales in October as generic drug further captured more market share from branded products. Item
> Generics giant Teva Pharmaceutical Industries ($TEVA) displayed the flip side of the patent cliff phenomenon by reporting better than expected earnings today. Story
And Finally... The FDA has announced a voluntary recall of Chinese bee pollen that contains undeclared Sibutramine, a previously approved controlled substance that was removed from the U.S. market in October 2010 for safety reasons. Release